Business Opportunities for Telemedicine During COVID-19 (pre-order)
Since early 2020, the world has been hit hard by the COVID-19 outbreak with new confirmed cases continuing to rise. Health systems worldwide have been overwhelmed with patients and people are worried about the risk of infection when going to hospitals. As a result, demand for telemedicine services has surged. This report discusses international policies, application services, business opportunities in the value chain, and key issues associated with telemedicine in recent years.
1. PREFACE
2. INTERNATIONAL POLICES
2.1 North America
2.1.1 The United States
2.1.2. Canada
2.2 Europe
2.1.1 Germany
2.1.2 UK
2.1.3 France
2.2 Asia
2.2.1 China
2.2.2 Japan
3. APPLICATION SERVICES
3.1 Virtual Medical Consultation
3.1.1 Teladoc Health
3.1.2 AmWell
3.2 Digital Diagnostics
3.2.1 Tyto Care
3.2.2 Healthy.io
3.3 Digital Pharmacy
3.3.1 Amazon Care
3.3.2 Ali Health
3.4 Telecare
3.4.1 Philips eICU
3.4.2 XR Health
4. BUSINESS OPPORTUNITIES IN TELEMEDICINE VALUE CHAIN
4.1 End Devices: In-home Biometric Devices Have Great Growth Potential
4.2 Network Communications: Increased Data Transmission in Hospitals Boosts Inelastic Demand
4.3 Application Services: Telemedicine as a Key Risk Control Technique in the Post-pandemic Era
5. KEY ISSUES
5.1 Improvement in Adaptability of Telemedicine Regulations is Required
5.2 Urgent Needs for Comprehensive Protection of Personal Health Data
6. MIC PERSPECTIVE
APPENDIX
List of Companies
2. INTERNATIONAL POLICES
2.1 North America
2.1.1 The United States
2.1.2. Canada
2.2 Europe
2.1.1 Germany
2.1.2 UK
2.1.3 France
2.2 Asia
2.2.1 China
2.2.2 Japan
3. APPLICATION SERVICES
3.1 Virtual Medical Consultation
3.1.1 Teladoc Health
3.1.2 AmWell
3.2 Digital Diagnostics
3.2.1 Tyto Care
3.2.2 Healthy.io
3.3 Digital Pharmacy
3.3.1 Amazon Care
3.3.2 Ali Health
3.4 Telecare
3.4.1 Philips eICU
3.4.2 XR Health
4. BUSINESS OPPORTUNITIES IN TELEMEDICINE VALUE CHAIN
4.1 End Devices: In-home Biometric Devices Have Great Growth Potential
4.2 Network Communications: Increased Data Transmission in Hospitals Boosts Inelastic Demand
4.3 Application Services: Telemedicine as a Key Risk Control Technique in the Post-pandemic Era
5. KEY ISSUES
5.1 Improvement in Adaptability of Telemedicine Regulations is Required
5.2 Urgent Needs for Comprehensive Protection of Personal Health Data
6. MIC PERSPECTIVE
APPENDIX
List of Companies
LIST OF TABLES
Table 1 Number of COVID-19 Cases in G7 and BRICS Countries
Table 1 Number of COVID-19 Cases in G7 and BRICS Countries
LIST OF FIGURES
Figure 1 Teladoc Health
Figure 2 AmWell
Figure 3 Tyto Care's Digital Stethoscope
Figure 4 Healthy.io's Urine Testing Device
Figure 5 Amazon Care
Figure 6 Ali Health
Figure 7 Philips eICU's Telecare Center
Figure 8 XRHealth
Figure 9 Telemedicine Industry Value Chain
Figure 1 Teladoc Health
Figure 2 AmWell
Figure 3 Tyto Care's Digital Stethoscope
Figure 4 Healthy.io's Urine Testing Device
Figure 5 Amazon Care
Figure 6 Ali Health
Figure 7 Philips eICU's Telecare Center
Figure 8 XRHealth
Figure 9 Telemedicine Industry Value Chain
